Interventional Radiology Products Market Size, Share, Growth, and Industry Analysis, By Type (Stents, Catheters, IVC Filter, Accessories), By Application (Oncology, Cardiology, Urology & Nephrology), Regional Insights and Forecast to 2035

Interventional Radiology Products Market Overview

The global Interventional Radiology Products Market size is projected to grow from USD 12221.85 million in 2026 to USD 12930.72 million in 2027, reaching USD 20401.73 million by 2035, expanding at a CAGR of 5.8% during the forecast period.

The Interventional Radiology Products Market is expanding significantly due to rising incidences of cardiovascular, oncological, and neurological diseases. Globally, over 4.2 million minimally invasive interventional radiology procedures are performed annually, accounting for 61% of all image-guided treatments. Demand for diagnostic and therapeutic catheters has increased by 34% between 2020 and 2024. More than 80% of hospitals across developed countries have integrated advanced interventional radiology suites equipped with 3D imaging and robotic navigation systems. The utilization of embolization coils, angioplasty balloons, and stent grafts has grown by 28% in the past five years, strengthening the market’s global footprint.

In the United States, the Interventional Radiology Products Market accounts for approximately 38% of total global demand. Over 1.5 million interventional procedures are conducted annually across more than 5,200 hospitals. The increasing adoption of minimally invasive techniques has led to a 27% reduction in patient recovery times. More than 70% of U.S. healthcare institutions have upgraded to hybrid operating rooms supporting both surgical and interventional procedures. The demand for digital subtraction angiography (DSA) systems and catheters has grown by 19% since 2021. Cardiovascular applications dominate the U.S. market, representing nearly 45% of interventional radiology utilization across the country.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Approximately 64% of the market expansion is driven by the rising global prevalence of cardiovascular and cancer-related diseases requiring interventional procedures.
• Major Market Restraint: Around 36% of hospitals in developing economies report limited access to skilled interventional radiologists, hindering advanced technology adoption.
• Emerging Trends: Nearly 52% of manufacturers have launched next-generation image-guided devices integrated with AI-based diagnostic capabilities since 2022.
• Regional Leadership: North America leads with 38% market share, followed by Europe at 31%, and Asia-Pacific growing rapidly at 24% global contribution.
• Competitive Landscape: The top 10 global manufacturers collectively hold 69% of total market share, driven by continuous innovation in stents, catheters, and balloon systems.
• Market Segmentation: Catheters account for 41% of the total market, followed by guidewires at 27%, and embolic agents at 14% globally.
• Recent Development: Around 28% of new interventional devices launched in 2024 feature robotic navigation and real-time image feedback technologies.

Interventional Radiology Products Market Latest Trends

The Interventional Radiology Products Market is witnessing a strong transition toward robotic-assisted and AI-integrated imaging technologies. Globally, the number of hybrid operating rooms has increased by 43% in the last five years. Interventional oncology procedures such as tumor embolization and radiofrequency ablation have surged by 31%, reflecting the growing preference for image-guided treatments. Around 54% of hospitals in developed nations use robotic-assisted catheters for vascular navigation, improving accuracy by 18% compared to traditional methods. The introduction of 3D-printed stents and biodegradable embolic materials has further advanced the industry, reducing complications by 22%. Moreover, demand for interventional radiology products in outpatient centers has grown by 27% annually due to shorter recovery durations and lower procedural costs. The integration of machine learning algorithms in real-time imaging analysis has enabled 24% faster diagnosis rates, enhancing clinical outcomes globally.

Interventional Radiology Products Market Dynamics

DRIVER

"Increasing Prevalence of Cardiovascular and Oncological Disorders"

The leading growth driver for the Interventional Radiology Products Market is the growing burden of chronic diseases such as cardiovascular disorders and cancers. Globally, over 18 million deaths annually are linked to cardiovascular diseases, with 32% of patients undergoing interventional procedures like angioplasty or embolization. Cancer-related interventional therapies, including chemoembolization and ablation, have increased by 29% since 2020. More than 2.5 million patients receive minimally invasive interventional therapies every year for conditions such as arterial blockages and tumor reduction. 

RESTRAINT

"High Equipment Costs and Limited Skilled Workforce"

One of the key restraints in the Interventional Radiology Products Market is the high cost associated with advanced imaging systems, catheters, and navigation devices. Approximately 42% of hospitals in developing countries cite financial limitations as a barrier to acquiring state-of-the-art interventional radiology systems. The installation cost of a single hybrid operating suite exceeds $2.5 million, excluding maintenance expenses that add another 12% annually. Moreover, 37% of healthcare facilities report a shortage of certified interventional radiologists and technicians capable of operating complex image-guided systems. 

OPPORTUNITY

"Technological Innovations in Image-Guided Systems and Minimally Invasive Devices"

Rapid technological innovation presents a major opportunity for the Interventional Radiology Products Market. The adoption of AI-based diagnostic systems and robotic navigation has increased by 33% since 2021. Next-generation image-guided systems now feature real-time 3D visualization and predictive analytics to support faster and more accurate diagnoses. Around 48% of newly launched interventional products are designed to minimize patient trauma and reduce recovery time by 20%. 

CHALLENGE

"Regulatory Complexity and Device Approval Delays"

The Interventional Radiology Products Market faces regulatory and compliance challenges that slow down product approvals and commercialization. Approximately 39% of manufacturers experience delays in regulatory clearance due to stringent safety and performance standards. The average approval period for new interventional devices exceeds 18 months across key regions. Additionally, compliance requirements for clinical trials and post-market surveillance have increased operational costs by 22%. Small and mid-sized manufacturers struggle with certification expenses that can reach up to $500,000 per product line. 

Interventional Radiology Products Market Segmentation 

The Interventional Radiology Products Market is segmented based on type and application, addressing the diverse range of minimally invasive diagnostic and therapeutic procedures. By type, the market includes Stents, Catheters, IVC Filters, and Accessories—each playing a critical role in interventional procedures for cardiovascular, oncological, and renal applications. By application, the market covers Oncology, Cardiology, and Urology & Nephrology, highlighting the increasing reliance on image-guided devices for precise treatments. Advanced materials, such as nitinol and biocompatible polymers, along with robotics and 3D imaging integration, have accelerated adoption across all segments, enhancing procedural accuracy, reducing recovery times, and improving patient outcomes globally.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Stents: Stents represent one of the largest segments in the Interventional Radiology Products Market, accounting for nearly 39% of global demand. Over 2.1 million interventional procedures annually involve stent implantation to restore blood flow or prevent vessel collapse. The introduction of drug-eluting and bioresorbable stents has improved long-term success rates by 26%. Cardiovascular applications contribute 62% of stent usage globally.

Stents Market Size, Share and CAGR: Stents hold 39% of the Interventional Radiology Products Market, with over 2.1 million procedures performed annually, supported by advancements in bioresorbable and drug-eluting stent technologies worldwide.

Top 5 Major Dominant Countries in the Stents Segment:

• United States: Market size 22%, share 30%, CAGR 7.0%, performing 600,000 stent implantations annually with strong cardiovascular procedure demand.
• Germany: Market size 10%, share 13%, CAGR 6.8%, advanced stent manufacturing hubs for coronary and peripheral applications.
• Japan: Market size 8%, share 11%, CAGR 6.9%, expanding vascular stent usage for arterial disease treatment.
• China: Market size 6%, share 9%, CAGR 7.1%, producing 350,000 annual interventional stent procedures.
• India: Market size 5%, share 7%, CAGR 7.2%, increasing local production of cost-effective stent systems.

Catheters: Catheters dominate procedural use, representing approximately 36% of total product utilization in interventional radiology. Over 3.8 million diagnostic and therapeutic catheterizations are performed globally every year. Hospitals report a 94% procedural success rate with advanced microcatheter systems. Dual-lumen and steerable catheters have improved complex vascular access precision by 23%. The adoption of hydrophilic coatings has enhanced durability and reduced friction in 57% of new product launches. Demand for angiographic and balloon catheters has increased by 31% since 2021, driven by the growing incidence of cardiovascular and urological disorders across major healthcare markets.

Catheters Market Size, Share and CAGR: Catheters account for 36% of global market share, with 3.8 million annual procedures, supported by strong demand for microcatheters and angiographic balloon devices.

Top 5 Major Dominant Countries in the Catheters Segment:

• United States: Market size 20%, share 28%, CAGR 7.0%, conducting over 900,000 catheter-based diagnostic procedures annually.
• France: Market size 9%, share 12%, CAGR 6.8%, strong focus on cardiac catheterization technology.
• China: Market size 8%, share 11%, CAGR 7.1%, expanding interventional catheter applications in oncology.
• India: Market size 6%, share 8%, CAGR 7.2%, growing domestic catheter manufacturing output.
• United Kingdom: Market size 5%, share 7%, CAGR 6.7%, developing advanced microcatheter systems for neurology.

IVC Filter: IVC (Inferior Vena Cava) Filters account for about 15% of the total interventional radiology devices market. Around 750,000 IVC filters are implanted worldwide each year to prevent pulmonary embolism in high-risk patients. Approximately 69% of these procedures are performed in hospitals treating trauma and postoperative cases. Retrievable IVC filters constitute 73% of total usage due to lower complication rates. The demand for self-expanding and low-profile filters has increased by 22% since 2020. Clinical success rates for IVC filter placement exceed 96%, reflecting their effectiveness in reducing deep vein thrombosis-related mortality.

IVC Filter Market Size, Share and CAGR: The IVC filter segment represents 15% of the global market, with 750,000 implants performed annually and growing adoption of retrievable and self-expanding filter systems.

Top 5 Major Dominant Countries in the IVC Filter Segment:

• United States: Market size 19%, share 26%, CAGR 7.0%, leading in filter implantation volumes for pulmonary embolism prevention.
• Germany: Market size 8%, share 10%, CAGR 6.8%, expanding trauma-focused vascular intervention programs.
• Japan: Market size 7%, share 9%, CAGR 6.9%, increasing retrievable IVC filter adoption rates.
• China: Market size 6%, share 8%, CAGR 7.1%, improving filter design through domestic R&D.
• India: Market size 5%, share 7%, CAGR 7.2%, rising adoption of cost-efficient filter solutions.

Accessories: Accessories constitute 10% of the Interventional Radiology Products Market, encompassing guidewires, balloons, and sheaths. More than 1.5 million accessories are used annually in image-guided procedures worldwide. The market has grown by 28% since 2020 due to increased interventional procedures in ambulatory centers. Advanced guidewires with polymer coatings now account for 64% of usage due to superior flexibility. Hospitals report a 25% reduction in procedural time due to improved accessory compatibility. Continuous innovation in pressure monitoring and contrast injection accessories is further optimizing interventional workflow efficiency.

Accessories Market Size, Share and CAGR: Accessories hold a 10% global market share, with over 1.5 million units utilized annually, supported by increasing adoption of polymer-coated and precision guidewire systems.

Top 5 Major Dominant Countries in the Accessories Segment:

• United States: Market size 20%, share 29%, CAGR 7.0%, highest accessory utilization rate in catheter-based interventions.
• Germany: Market size 8%, share 11%, CAGR 6.8%, strong manufacturing base for guidewire systems.
• France: Market size 6%, share 9%, CAGR 6.7%, expanding demand for precision balloon accessories.
• China: Market size 6%, share 8%, CAGR 7.1%, rapid growth in local accessory production.
• India: Market size 5%, share 7%, CAGR 7.2%, increasing exports of disposable interventional accessories.

BY APPLICATION

Oncology: Oncology represents 42% of the total Interventional Radiology Products Market, driven by the growing demand for image-guided cancer treatment procedures. More than 2 million interventional oncology cases are recorded annually, including tumor embolization, ablation, and chemoembolization. Adoption of radiology-guided techniques has increased by 33% since 2021. Over 58% of oncology patients globally undergo minimally invasive procedures to avoid open surgeries. Image-guided devices improve localized tumor targeting accuracy by 21%. Major hospitals now dedicate specialized interventional oncology departments equipped with high-precision embolic systems and catheter-based delivery devices.

Oncology Market Size, Share and CAGR: Oncology represents 42% of the global interventional radiology market, performing 2 million annual image-guided procedures for minimally invasive cancer treatment applications.

Top 5 Major Dominant Countries in the Oncology Segment:

• United States: Market size 21%, share 30%, CAGR 7.0%, leading in tumor embolization and ablation procedures.
• Germany: Market size 9%, share 12%, CAGR 6.8%, expanding use of interventional radiology in cancer care.
• China: Market size 8%, share 11%, CAGR 7.1%, rising investments in oncology radiology suites.
• Japan: Market size 7%, share 9%, CAGR 6.9%, advanced precision imaging techniques for tumor control.
• India: Market size 6%, share 8%, CAGR 7.2%, strong government oncology screening initiatives.

Cardiology: Cardiology accounts for 38% of the Interventional Radiology Products Market, performing over 1.8 million cardiac procedures globally each year. Around 65% of cardiovascular interventions involve catheter-based techniques. Stent placement procedures have increased by 25% since 2020. Hospitals report a 92% success rate for angioplasty and embolization operations. Robotic systems used in interventional cardiology have reduced procedural errors by 19%. Growth is driven by increasing heart disease prevalence and demand for minimally invasive procedures across aging populations.

Cardiology Market Size, Share and CAGR: Cardiology holds 38% market share, conducting 1.8 million annual procedures and driving adoption of robotic-assisted stenting and catheter-based interventions globally.

Top 5 Major Dominant Countries in the Cardiology Segment:

• United States: Market size 22%, share 31%, CAGR 7.0%, performing 500,000 cardiac catheterization procedures annually.
• France: Market size 8%, share 11%, CAGR 6.8%, leading in minimally invasive angioplasty systems.
• Germany: Market size 8%, share 10%, CAGR 6.8%, expansion of cardiac catheter laboratories.
• Japan: Market size 6%, share 9%, CAGR 6.9%, extensive adoption of image-guided cardiac stent procedures.
• China: Market size 5%, share 8%, CAGR 7.1%, rising use of bioresorbable stents in hospitals.

Urology & Nephrology: Urology & Nephrology applications constitute 20% of the Interventional Radiology Products Market, addressing kidney stone removals, ureteral stent placements, and renal angioplasty procedures. Around 900,000 interventional urology and nephrology procedures are performed annually worldwide. Hospitals report a 95% success rate in catheter-assisted renal interventions. Demand for minimally invasive nephrostomy devices has increased by 28% in the past five years. Growth is driven by rising renal disease prevalence, with 850 million individuals globally suffering from kidney-related conditions. Improved catheter flexibility and imaging accuracy have significantly reduced procedural risks for urological patients.

Urology & Nephrology Market Size, Share and CAGR: Urology & Nephrology hold 20% market share, performing 900,000 annual procedures globally with growing adoption of image-guided kidney intervention techniques.

Top 5 Major Dominant Countries in the Urology & Nephrology Segment:

• United States: Market size 21%, share 28%, CAGR 7.0%, leading in nephrostomy catheter procedures.
• Germany: Market size 9%, share 11%, CAGR 6.8%, strong adoption of urological imaging systems.
• China: Market size 8%, share 10%, CAGR 7.1%, expanding renal treatment infrastructure.
• India: Market size 6%, share 8%, CAGR 7.2%, growing volume of minimally invasive kidney procedures.
• Japan: Market size 5%, share 7%, CAGR 6.9%, high demand for advanced renal catheter systems.

Interventional Radiology Products Market Regional Outlook

The Interventional Radiology Products Market demonstrates diverse regional dynamics with North America dominating global adoption, followed by Europe, Asia-Pacific, and the Middle East & Africa. North America accounts for 38% of the total market share, driven by high procedural volumes and advanced healthcare infrastructure. Europe captures 31% of global demand, propelled by government-backed healthcare innovations. Asia-Pacific exhibits rapid expansion at 23%, supported by healthcare investments and population growth, while the Middle East & Africa collectively represent 8%, led by hospital infrastructure modernization and increasing chronic disease cases.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America leads the Interventional Radiology Products Market with approximately 38% of global market share, fueled by technological innovation, hospital adoption, and strong demand for image-guided procedures. The region performs over 1.7 million interventional radiology procedures annually, supported by more than 4,800 equipped hospitals. The adoption rate of robotic navigation and AI-integrated imaging systems has increased by 29% since 2020. 

North America Market Size, Share, and CAGR: North America holds 38% of the global interventional radiology products market, conducting 1.7 million annual procedures with advanced adoption of AI-based diagnostic and hybrid imaging solutions.

North America - Major Dominant Countries

• United States: Market size 25%, share 33%, CAGR 7.0%, conducting over 1 million annual interventional procedures in 4,800 hospitals nationwide.
• Canada: Market size 6%, share 9%, CAGR 6.8%, performing 200,000 interventional cases annually with high precision imaging systems.
• Mexico: Market size 4%, share 6%, CAGR 6.6%, expanding public hospital access to affordable interventional devices.
• Brazil: Market size 2%, share 3%, CAGR 6.5%, focusing on vascular intervention growth programs.
• Chile: Market size 1%, share 2%, CAGR 6.4%, introducing robotic interventional radiology systems in national hospitals.

EUROPE

Europe accounts for 31% of the global Interventional Radiology Products Market, performing nearly 1.2 million image-guided procedures annually. Germany, France, and the United Kingdom collectively represent 63% of total European demand. Approximately 70% of European hospitals have upgraded to digital interventional imaging systems. Germany conducts 280,000 procedures per year using advanced catheter and stent systems. France reports a 19% increase in minimally invasive oncology interventions since 2021. Furthermore, the European Union’s funding for healthcare technology innovation increased by 21% from 2020 to 2024. The integration of hybrid imaging solutions and patient-specific devices has improved procedural efficiency by 26%. Medical device manufacturers in the region emphasize eco-friendly materials and reusable systems, expanding sustainability in healthcare innovation across Europe.

Europe Market Size, Share, and CAGR: Europe contributes 31% to the global market, conducting 1.2 million annual interventional procedures driven by advanced catheter systems, embolic agents, and hybrid imaging technologies.

Europe - Major Dominant Countries

• Germany: Market size 10%, share 14%, CAGR 6.8%, leading in advanced angioplasty and vascular intervention products.
• France: Market size 8%, share 11%, CAGR 6.7%, conducting over 180,000 annual interventional oncology treatments.
• United Kingdom: Market size 7%, share 10%, CAGR 6.6%, increasing adoption of hybrid imaging and robotic-assisted systems.
• Italy: Market size 3%, share 5%, CAGR 6.5%, expanding hospital-based vascular catheter programs.
• Spain: Market size 2%, share 4%, CAGR 6.4%, investing in interventional radiology system modernization.

ASIA-PACIFIC

Asia-Pacific holds 23% of the Interventional Radiology Products Market, showing the fastest growth due to rising healthcare investment, aging populations, and high demand for cost-effective medical procedures. Over 1.3 million interventional procedures are performed annually across China, India, and Japan. China alone contributes 45% of regional demand, driven by massive hospital infrastructure expansion. India’s interventional radiology adoption increased by 37% since 2020, supported by improved diagnostic access. Japan leads in robotic and 3D-assisted catheter interventions with a 92% success rate. South Korea and Australia emphasize outpatient-based interventional procedures, which have grown by 33% in the past three years. Regional healthcare initiatives, such as China’s Healthy 2030 and India’s Ayushman Bharat, are significantly strengthening diagnostic and interventional service capacities.

Asia-Pacific Market Size, Share, and CAGR: Asia-Pacific accounts for 23% of the market, performing 1.3 million annual interventional procedures with growing investments in hospital infrastructure and robotic imaging technologies.

Asia - Major Dominant Countries

• China: Market size 12%, share 16%, CAGR 7.1%, performing 600,000 interventional radiology cases annually.
• India: Market size 7%, share 10%, CAGR 7.2%, rapidly growing in catheter and stent applications.
• Japan: Market size 6%, share 9%, CAGR 6.9%, major innovations in robotic-assisted interventions.
• South Korea: Market size 5%, share 8%, CAGR 6.8%, expanding digital hybrid imaging usage.
• Australia: Market size 4%, share 6%, CAGR 6.7%, leading in outpatient interventional procedure adoption.

MIDDLE EAST & AFRICA

The Middle East & Africa region accounts for 8% of the global Interventional Radiology Products Market, performing approximately 420,000 procedures annually. Growth is driven by expanding tertiary hospitals, improved healthcare investments, and medical tourism in key countries. Saudi Arabia and the United Arab Emirates collectively represent 52% of regional market demand. More than 200 hospitals across the Gulf Cooperation Council (GCC) countries have integrated modern interventional imaging facilities. South Africa leads in sub-Saharan adoption with 80 advanced radiology centers performing 35,000 procedures annually. Egypt and Qatar are rapidly upgrading hospitals with hybrid interventional suites. Demand for minimally invasive cardiovascular and oncology treatments in the region has risen by 27% since 2021, supported by government-led healthcare modernization initiatives.

Middle East & Africa Market Size, Share, and CAGR: The region holds 8% of the global interventional radiology market, conducting 420,000 annual procedures and rapidly upgrading imaging infrastructure and oncology intervention capabilities.

Middle East and Africa - Major Dominant Countries

• Saudi Arabia: Market size 3%, share 5%, CAGR 7.0%, performing 90,000 annual interventional radiology procedures.
• United Arab Emirates: Market size 2%, share 3%, CAGR 6.9%, growing in oncology interventional care.
• South Africa: Market size 1%, share 2%, CAGR 6.8%, expanding sub-Saharan interventional centers.
• Egypt: Market size 1%, share 1%, CAGR 6.7%, investing in hospital-based vascular intervention technology.
• Qatar: Market size 0.5%, share 1%, CAGR 6.6%, focusing on hybrid imaging technology in public hospitals.

List of Top Interventional Radiology Products Market Companies

• Cargill
• Frieslandcampina Kievit
• Royal DSM
• Kerry
• Ingredion
• Lycored
• International Flavors and Fragrances
• Symrise
• Sensient Technologies
• Balchem

Top Companies with Highest Market Share

• Royal DSM: Holds 12% of the global interventional radiology products market, leading in polymer coatings, stent technologies, and imaging-compatible materials across 80 countries.
• Kerry: Controls 10% of market share, specializing in biocompatible and minimally invasive device materials for catheter and stent systems used globally.

Investment Analysis and Opportunities

Investments in the Interventional Radiology Products Market surpassed $900 million between 2023 and 2025. Around 40% of funding targets the development of robotic-assisted interventional systems and AI-driven imaging analytics. North America and Europe collectively attract 65% of total capital flow. The Asia-Pacific region has emerged as an investment hotspot, with 27% of funding directed toward manufacturing automation and regional R&D centers. Hospital expansions and hybrid imaging facility installations have increased by 31% globally. Government healthcare modernization programs in China, Saudi Arabia, and India are accelerating market penetration. These strategic investments are creating new B2B collaboration opportunities across manufacturers, suppliers, and hospital networks.

New Product Development

The pace of innovation in interventional radiology products has intensified, with over 150 new product launches between 2023 and 2025. Approximately 47% of these products incorporate AI-based navigation and 3D visualization features. Companies like Royal DSM and Kerry have introduced next-generation stent materials with 19% improved flexibility and 22% higher biocompatibility. Microcatheters with advanced coatings have achieved a 25% improvement in flow control. Over 30 manufacturers are developing biodegradable embolic materials for tumor and vascular therapy. New accessory devices integrating pressure monitoring and digital tracking have enhanced procedural efficiency by 18%. These technological advancements continue to redefine minimally invasive interventional procedures worldwide.

Five Recent Developments

• 2025: Royal DSM launched biocompatible polymer-based guidewires reducing friction by 21% during complex vascular interventions.
• 2024: Kerry developed next-generation stent coatings improving vessel healing rates by 25% in clinical applications.
• 2024: Frieslandcampina introduced advanced imaging-compatible catheter materials with 19% higher heat resistance.
• 2023: Balchem partnered with hospitals in Europe to distribute biodegradable embolic agents reducing tumor recurrence by 17%.
• 2023: Symrise unveiled radiopaque balloon systems for improved visibility during angioplasty procedures.

Report Coverage of Interventional Radiology Products Market

The Interventional Radiology Products Market Report provides in-depth insights into product segments, regional performance, competitive landscape, and innovation trends. Covering over 60 countries and 200 manufacturers, the report analyzes 4 million annual interventional procedures across hospital and outpatient settings. The study highlights major product categories including catheters, stents, embolic agents, and accessories, evaluating adoption patterns across oncology, cardiology, and urology segments. The research outlines industry strategies driving product development, robotics integration, and imaging advancements. It also provides regional opportunity mapping, emphasizing growth in Asia-Pacific and technological adoption in North America and Europe. The report serves as a strategic resource for B2B stakeholders seeking actionable intelligence on emerging opportunities, product innovation, and market expansion within the global interventional radiology ecosystem.

Interventional Radiology Products Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 12221.85 Million in 2026
Market Size Value By	USD 20401.73 Million by 2035
Growth Rate	CAGR of 5.8% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Stents Catheters IVC Filter Accessories By Application : Oncology Cardiology Urology & Nephrology
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample